National
‘Worldwide’ LGBT marches planned in April
Facebook organizers not connected to established LGBT organizations
A Facebook group of LGBT rights advocates that claims to have 20,000 members is organizing a series of simultaneous LGBT civil rights marches in the U.S. and abroad that are scheduled to take place April 21.
Oklahoma City gay activist Joe Knudson, who initiated what he hopes will be the world’s largest peaceful protest on behalf of LGBT equality, says organizers have so far lined up marches in 10 U.S. cities, including Washington, D.C; New York City; Chicago; Atlanta; and Hampton, Va.
He said the only location outside the U.S. confirmed for one of the marches so far is an as yet to be selected city in Pakistan. A number of participating cities in Europe are expected to be announced soon, he said.
“The Worldwide LGBT Civil Rights March in 2012 is already gathering sponsors and supporters by the thousands, as well as initial lead organizers from around the world,” organizers said in an October posting on Facebook.
“The march will be held worldwide at various locations at the same time, as well as an online news media event that will keep everyone posted on the events at all locations,” the Facebook posting says.
It adds, “This event has been created by the fastest growing LGBT Equality group, with members from around the world – Let’s Reach 1 Million People Campaign…It’s a start! LGBT Equality.”
Knudson, 56, said he started that group in the late spring or early summer of 2011 with the aim of building a grassroots LGBT advocacy campaign with an international reach. He said he and others involved with the group came up with the idea of the worldwide LGBT marches.
In his Facebook biography, Knudson says he began his career in the banking industry and came out as gay later in life, after being married to a woman and raising children. He has since founded a publishing company in Oklahoma City that he created to publish his recent book, “Living the Difference: An Enlightening Story Revealed for People of All Ages, Straight or Gay.”
Knudson said the book describes his struggles in reconciling himself as a gay man who has embraced his sexual orientation and now yearns to help others do the same and promote the cause of LGBT equality.
A Washington Blade spot survey this week of several of the nation’s largest LGBT national and state advocacy organizations, including the Human Rights Campaign and the National Gay and Lesbian Task Force, found that all but one were unaware of the global marches.
Heather Cronk, a spokesperson for the national direct action group GetEqual, said GetEqual would play some role in the marches but she did not get back by press time with details about GetEqual’s involvement in the events.
Spokespersons for the other groups said no one had contacted them so far about the planned worldwide marches and they had not heard anything about the events until contacted this week by the Blade.
Among the groups unaware of the marches were HRC, Task Force, the Gay & Lesbian Victory Fund, the National Center for Transgender Equality, the Empire State Pride Agenda of New York, the New York City LGBT Community Center, and the Gertrude Stein Democratic Club, D.C.’s largest LGBT political group. The National Black Justice Coalition, a Washington, D.C.-based LGBT group, did not respond by press time to an inquiry about whether it was aware of the marches.
Knudson said the New York City march was being coordinated by Christianne Bharath, a 16-year-old high school student on Long Island who says she serves as president of her school’s Gay-Straight Alliance group.
“It’s still in the early stages, Bharath told the Blade on Tuesday. “We’re getting the LGBT Center in with us and also the Long Island Gay and Lesbian Youth Center,” of which she said she’s also involved.
Cyndi Creager, a spokesperson for the New York City LGBT Center, said no one from the march group had contacted the center as of this week. Creager said the center would consider whether to provide support for the New York march after learning more about it.
Veteran New York lesbian activist Roberta Sklar, who serves as communications director for the New York-based International Gay and Lesbian Human Rights Commission, said her group also had not been contacted by organizers of the marches.
IGLHRC has contacts with LGBT organizations and activists throughout the world, especially in Latin American countries.
Task Force spokesperson Inga Sorenson said no one from the Worldwide March organization has registered to participate in the Task Force’s annual Creating Change conference scheduled for later this month in Baltimore. The Creating Change conference is considered the preeminent annual gathering of the nation’s LGBT activist and movement leaders.
The designated organizer of the D.C. march, Curtis Sledge, said he lives in Richmond and doesn’t often come to D.C. He said he has changed his work hours as a manager of a McDonald’s restaurant in Richmond to enable him to come to D.C. to make arrangements for the march, including the filing of an application for parade permits with D.C. police and the National Park Service.
Sledge said organizers haven’t decided yet on the exact route of the D.C. march, but they are leaning toward having the march travel past the Lincoln Memorial and the Martin Luther King Jr. memorial located next to the National Mall.
He said organizers are planning for a rally with speakers to take place at the end of the march but haven’t decided yet where that would be held. Lesbian comedian Wanda Sykes is among those invited to speak and perform at the event, Sledge said.
“I’m just getting started,” he said. “I will be talking to people at HRC and I will contact D.C.-area universities to get them involved.”
March organizers said they have so far confirmed marches on April 21 in these cities: D.C.; New York City; Albany, N.Y.; Atlanta; Chicago; Oklahoma City; Hampton, Va.; Dayton, Ohio; Cincinnati-Northern Kentucky region; and Portland, Ore., with Pakistan set as the only country outside the U.S. so far.
Knudson and others involved in organizing the marches acknowledge that they don’t have longstanding ties with existing LGBT organizations but hope to build those ties during the final planning stages for the marches.
D.C. gay activist Phil Attey, who has used Facebook to organize LGBT-related endeavors, said Knudson contacted him last year to seek his help with the worldwide march project. Attey said he supports the project and thinks the decision by organizers to hold marches in many cities rather than just Washington was an “excellent idea.” Attey called on march organizers to focus their attention in the U.S. on electing LGBT supportive members of Congress in the November election.
“I will be putting my energy into re-electing the president and electing members of Congress who support our civil rights,” he said. “I think that’s what they should be doing.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
‘Dogs of Venice’ looks at love lost and rediscovered
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Lighting candles in a time of exhaustion
Why queer spaces often fail South Asian women
